Stay updated with breaking news from Nasdaq Tern. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
JMP Securities reissued their market outperform rating on shares of Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) in a research report sent to investors on Wednesday, Benzinga reports. They currently have a $17.00 target price on the stock. TERN has been the subject of a number of other research reports. The Goldman Sachs Group upped their […]
Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) had its target price increased by JPMorgan Chase & Co. from $6.00 to $9.00 in a research report report published on Wednesday morning, Benzinga reports. The firm currently has a neutral rating on the stock. A number of other equities research analysts have also issued reports on the company. […]
Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) and Phibro Animal Health (NASDAQ:PAHC – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, institutional ownership, valuation, profitability and risk. Insider & Institutional Ownership 49.2% of Phibro Animal […]
Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) had its price target raised by analysts at HC Wainwright from $7.00 to $11.00 in a note issued to investors on Wednesday, The Fly reports. HC Wainwright’s price target indicates a potential upside of 2.90% from the company’s current price. A number of other analysts have also weighed in […]
Terns Pharmaceuticals (NASDAQ:TERN – Get Rating) issued its quarterly earnings data on Monday. The company reported ($0.29) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.40) by $0.11, MarketWatch Earnings reports. Terns Pharmaceuticals Stock Up 5.8 % Terns Pharmaceuticals stock opened at $9.44 on Tuesday. The stock’s 50 day moving average is […]